Current:Home > BackNovo Nordisk will cut some U.S. insulin prices by up to 75% starting next year-DB Wealth Institute B2 Expert Reviews
Novo Nordisk will cut some U.S. insulin prices by up to 75% starting next year
View Date:2025-01-13 04:59:24
Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly.
The Danish drugmaker said Tuesday that pre-filled pens and vials of long- and short-acting insulins will see list price reductions. They include Levemir, Novolin, NovoLog and NovoLog Mix70/30.
Novo also will drop the list price of unbranded products like Insulin Aspart to match the lower price of the branded insulins.
The price cuts go into effect Jan. 1. A vial of NovoLog and NovoLog Mix 70/30 will drop 75% to $72.34 from $289.36. FlexPen options will fall to $139.71 from more than $500.
Levemir and Novolin vials and FlexPens will drop 65% from their current list prices.
List prices are what a drugmaker initially sets for a product and what people who have no insurance or plans with high deductibles are sometimes stuck paying.
Patient advocates have long called for insulin price cuts to help uninsured people who would not be affected by price caps tied to insurance coverage. They have noted that high insulin prices force many people to ration doses, which can be dangerous for their health.
Research has shown that prices for insulin have more than tripled in the last two decades. Pressure is growing on drugmakers to help patients.
Insulin affordability in the United States depends largely on whether patients have health insurance and the details of that coverage. People with employer-sponsored coverage, for instance, may pay little out of pocket for their insulin or they might pay hundreds of dollars if they must first meet a high deductible before the coverage kicks in.
High deductibles also are common with coverage purchased through the individual insurance market.
Major insulin makers like Lilly, Novo and the French pharmaceutical company Sanofi have said they offer several assistance programs to help patients with costs. Those can include free refills for people with low incomes and cheaper versions of older insulins.
But high list prices remain a problem.
Eli Lilly and Co. CEO David Ricks noted earlier this month that discounts the drugmaker offers from its list prices often don't reach patients through insurers or pharmacy benefit managers.
The Indianapolis-based drugmaker said March 1 that it will cut the list prices for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% or more in the fourth quarter, which starts in October.
The federal government in January started applying a $35 cap on monthly out-of-pocket costs to patients with coverage through its Medicare program for people age 65 and older or those who have certain disabilities or illnesses.
Insulin is made by the pancreas and used by the body to convert food into energy. People who have diabetes don't produce enough insulin. Those with Type 1 diabetes must take insulin every day to survive.
More than 8 million Americans use insulin, according to the American Diabetes Association.
The Wall Street Journal first reported the price cuts Tuesday morning.
veryGood! (95932)
Related
- AIT Community Introduce
- The 49ers place rookie Ricky Pearsall on the non-football injury list after shooting
- Tennis Player Yulia Putintseva Apologizes for Behavior Towards Ball Girl at US Open Amid Criticism
- Arkansas woman pleads guilty to bomb threat against Gov. Sarah Huckabee Sanders
- Judge set to rule on whether to scrap Trump’s conviction in hush money case
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Hands Down
- Prince Carl Philip and Princess Sofia of Sweden Expecting Baby No. 4
- Explosion levels southwest Louisiana home, killing teen from Alabama and injuring 5
- Arizona Supreme Court declines emergency request to extend ballot ‘curing’ deadline
- Do smartphone bans work if parents push back?
Ranking
- RHOBH's Erika Jayne Reveals Which Team She's on Amid Kyle Richards, Dorit Kemsley Feud
- Simone Biles Says She's No Longer Performing This Gymnastic Move in the Most Unforgettable Way
- Overnight shootings along Seattle-area interstate injure 4
- Trent Williams ends holdout with 49ers with new contract almost complete
- Texas now tops in SEC? Miami in trouble? Five overreactions to college football Week 11
- You Have 24 Hours To Get 50% Off Ashley Graham’s Self-Tanner, Madison LeCroy’s Eye Cream & $7 Ulta Deals
- Can dogs eat watermelon? Ways to feed your pup fruit safely.
- 7 people killed in Mississippi bus crash were all from Mexico, highway patrol says
Recommendation
-
‘Emilia Pérez’ wouldn’t work without Karla Sofía Gascón. Now, she could make trans history
-
Real Housewives of Beverly Hills Star Kyle Richards Says This $29.98 Bikini Looks Like a Chanel Dupe
-
Fantasy football 2024 draft rankings: PPR and non-PPR
-
Prosecutors drop fraud case against Maryland attorney
-
Hill House Home’s Once-A-Year Sale Is Here: Get 30% off Everything & up to 75% off Luxury Dresses
-
Prince Carl Philip and Princess Sofia of Sweden Expecting Baby No. 4
-
Nearly 50 years after being found dead in a Pennsylvania cave, ‘Pinnacle Man’ is identified
-
Murder on Music Row: Predatory promoters bilk Nashville's singing newcomers